Ca ++ -channel antagonist verapamil and ATP-sensitive K + -channel opener pinacidil are known to decrease the rise in extracellular K + ([K   + ]e) level and pH (pHe) that occurs during reversible acute myocardial ischemia and to lessen the accompanying activation delay. Verapamil is also known to decrease the incidence of ventricular tachycardia (VT)/fibrillation (VF) during acute myocardial ischemia; however, the effects of ATP-sensitive K + -channel opener on the incidence of VT/VF are controversial. We studied, in an in vivo pig model, the effects of verapamil and pinacidil on the changes in [K + ]e level and pHe, local activation, and the incidence of VT/VF during 60 minutes of ischemia. Thirty-one pigs were divided into 2 groups: a verapamil group (9 control pigs and 8 verapamil-treated pigs) and pinacidil group (5 control pigs and 9 pinacidil-treated pigs). In the verapamil group, VF developed in 1 of the 9 control pigs, whereas no VF developed in 8 verapamil-treated pigs. In the pinacidil group, VF developed in 3 of the 5 control pigs and all 9 pinacidil-treated pigs. Under verapamil treatment (versus the control condition), onset of the second rise in (Int Heart J 2018; 59: 589-595)
]e) level and pH (pHe) that occurs during reversible acute myocardial ischemia and to lessen the accompanying activation delay. Verapamil is also known to decrease the incidence of ventricular tachycardia (VT)/fibrillation (VF) during acute myocardial ischemia; however, the effects of ATP-sensitive K + -channel opener on the incidence of VT/VF are controversial. We studied, in an in vivo pig model, the effects of verapamil and pinacidil on the changes in [K + ]e level and pHe, local activation, and the incidence of VT/VF during 60 minutes of ischemia. Thirty-one pigs were divided into 2 groups: a verapamil group (9 control pigs and 8 verapamil-treated pigs) and pinacidil group (5 control pigs and 9 pinacidil-treated pigs). In the verapamil group, VF developed in 1 of the 9 control pigs, whereas no VF developed in 8 verapamil-treated pigs. In the pinacidil group, VF developed in 3 of the 5 control pigs and all 9 pinacidil-treated pigs. Under verapamil treatment (versus the control condition), onset of the second rise in ]e) level [1] [2] [3] [4] [5] [6] [7] and extracellular pH (pHe) [8] [9] [10] during the initial 8-15 minutes of acute myocardial ischemia have been well characterized in animal models. This period corresponds to the early phase of ventricular arrhythmia 4) and to the phase of reversible myocardial cell injury. 1, 11) We know that irreversible cell injury occurs after prolonged ischemia; however, the changes in [K + ]e level and pHe during the extended periods of ischemia have not been well characterized. A triphasic rise in [K + ]e level during prolonged ischemia has been reported; 1, 2, 4, 5, 12) however, this rise has not been characterized in detail. Specifically, the exact time course, magnitude, and regional characteristics of the changes in [K + ]e level and pHe during prolonged ischemia have not been studied systematically. In addition, the effects of pharmacological interventions on simultaneously measured changes in [K + ]e level and pHe during prolonged ischemia remain unclear, as is the incidence of ventricular tachycardia/fibrillation. Because the onset of irreversible cell injury occurs during the first 60 minutes of ischemia, this time period is of considerable interest.
Previously, we and other investigators described the use of ion-selective plunge electrodes in in situ pig heart to study the changes in myocardial [K + ]e level and pHe and local activation during brief periods of myocardial ischemia. 6, 13) We used a similar method to study the changes in myocardial [K + ]e level and pHe and the effects of verapamil and pinacidil on these changes during 60 minutes of ischemia, and we report our findings herein.
Methods
Experimental preparation: Thirty-one domestic pigs of both sex and weighing 30-50 kg were used in the study. Animal care conformed to the Position of the American Heart Association on the Use of Research Animals and was in accordance with the accepted guidelines for the care and treatment of experimental animals at the University of North Carolina. Approval for the study was obtained from the University of North Carolina at Chapel Hill's Institutional Animal Care and Use Committee. The experimental procedure was similar to those previously reported. [14] [15] [16] [17] All 31 pigs were anesthetized with sodium pentobarbital (25 mg/kg), followed by α-chloralose as needed. Mechanical ventilation and supplemental oxygen were provided via an endotracheal tube and a Harvard respirator. Arterial blood gases were monitored, and appropriate ventilator adjustments were made for the maintenance of arterial PO2 at > 80 mmHg and pH at 7.35-7.45. Femoral artery and femoral venous catheters were used for monitoring the arterial blood pressure (Millar Pressure Transducer, Millar, Inc. Houston, TX, USA) and for administering fluids and drugs. Core temperature was continuously monitored with a temperature probe (Yellow Springs Instrument Co., Yellow Springs, OH, USA). Heating blankets were used to maintain the animals' body temperature at 36-37 . The heart was exposed by median sternotomy and suspended in a pericardial cradle. A site midway along the left anterior descending coronary artery (LAD) that was free of branches was selected for cannulation and dissected from the surrounding tissue. The epicardial margin between the ischemic and nonischemic tissue was identified by a brief occlusion of the vessel at this site, and 4-6 ion-selective electrode groups were placed at multiple locations at the center of the ischemic zone, defined as the region >10 mm inside the visible cyanotic border, and in the normal circulation (nonischemic) zone.
After electrode placement, systematic heparin (a bolus of 10,000 U followed by infusion at 2000 U/hour) was administered. A carotid artery-to-LAD shunt was created by placing a polyethylene catheter (Intramedic, ID 1.77 mm) in the aortic arch through the right carotid artery, routing the catheter through a Masterflex roller pump, and connecting the distal end to a cannula (Insul-Tab 7444 AWG 19, 0.07OD) that was placed in the LAD at the previously selected site. Placement of the shunt in the LAD took approximately 2-3 minutes. To ensure that the duration of ischemia during the shunt placement was consistent, the ischemia was maintained for a total of 5 minutes in each pig. 18) Perfusion to the distal LAD was provided by the shunt and maintained at 1.2 mL/kg body weight/ minute, which was previously known to yield a flow of 1.2-1.5 mL/g heart tissue/minute. 19) Atrial pacing was used to increase the heart rate. Arterial blood pressure and a lead II electrocardiogram were recorded on a 12-channel Graphtec Linearcorder (Graphtec, Yokohama, Kanagawa, Japan) and were continuously monitored throughout the experiments. Ion-selective electrodes: Ion-selective plunge electrodes were fashioned and calibrated as previously described. 18) Briefly, one end of a Teflon-coated silver wire (0.007 in diameter) was chloridized by soaking it in sodium hypochlorite; it was then covered with a cellulose acetatetitanium dioxide sponge. K + ion-and H + ion-sensitive electrodes were made by covering the sponge with a polyvinylchloride (PVC)-valinomycin-or PVC-tridodecylamine-based membrane. Reference electrodes were fashioned in an analogous manner but lacked the ion-selective membrane. A K + -sensitive electrode, H + -sensitive electrode, and reference electrode constituted an electrode group. Electrodes were calibrated before each experiment in the standard solution (3 and 10 mmol/L KCl for the K + -sensitive electrodes and pH 8 and pH 6 for the H + -sensitive electrodes). Only electrodes with a stable baseline drift (< 1 mV/hour) and 95%-105% of the predicted Nernstian slope (56-62 mV shift per decade change in K + activity at room temperature) were used. The electrode group was threaded into a 20-gauge hypodermic needle, which was used to insert the electrodes into the midmyocardium to a depth of 4-6 mm. We placed 4-6 K + -and pH-sensitive electrodes in the ischemic midmyocardium. The in vivo performances of these electrodes were tested by the methods previously described. 19) At the end of each experiment, the electrodes were removed from the heart and were retested in vitro to confirm their stable function throughout the experiment. The needle was then withdrawn, leaving the electrodes imbedded in the myocardium. Experimental protocol: Pigs were randomly assigned to a verapamil group [control pigs (n = 9) or verapamiltreated pigs (n = 8)] or pinacidil group [control pigs (n = 5) or pinacidil-treated pigs (n = 9)]. In both groups, myocardial ischemia was induced by abrupt cessation of flow through the LAD shunt 50 minutes after cannulation of the LAD. Five% ethanol, a pinacidil solvent, were given as a placebo in the 5 pigs of the pinacidil group as the same speed as pinacidil administration pigs. Verapamiltreated pigs were administered an intravenous bolus of 0.2 mg/kg verapamil, infused over a 20-minute period beginning 35-40 minutes prior to the LAD occlusion. The verapamil bolus was followed by a maintenance infusion of 0.0065 mg/kg/hour. 14, 19, 20) Pinacidil-treated pigs were administered 500 μM/L of pinacidil infused through the side arm of the shunt at a rate calculated to produce a concentration of 10 μM/L (n = 2) or 25 μM/L (n = 7) in the blood shunted to the LAD. 16) Pinacidil infusion was initiated after 30 minutes of reperfusion and maintained for 20 minutes. In both the verapamil and pinacidil groups, right atrial pacing at 120 beats/second was initiated 10 minutes prior to the LAD occlusion and was maintained throughout the remainder of the experiment. Data collection and analysis: Signals from all electrodes were individually amplified by high-impedance amplifiers. The amplified signals from all electrodes, along with the lead II electrocardiogram, were digitized with the use of an analog-to-digital converter (Phoenix Data) and were simultaneously sampled (1000 samples per second) every 15 seconds during myocardial ischemia and stored on a MicroVAX II/GPX computer (Digital Equipment Corporation, Maynard, MA, USA). ]e level at the same site in the myocardium, and 3) the minimum pHe attained. In 3 pigs that were administered pinacidil, the transmembrane action potentials were recorded from the epicardial surface of the ischemic zone, as previously described. 16, 17) Statistical analysis: Values are presented as mean ± SEM unless otherwise indicated. Between-group differences in [K + ]e level and pHe were analyzed by the Mann-Whitney U test or Fisher's exact probability test, as appropriate. All statistical analyses were performed with StatView 5.0 software (SAS Institute, Cary, NC), and P < 0.05 was considered as statistically significant.
Results

Changes in [K +
]e level and pHe that occurred in the center of the ischemic zone during the 60-minute occlusion period under the control condition during an experiment are presented in Figure 1 Table I ). The fall in pHe did not occur as rapidly in the verapamil group as it did in the control group, and neither the minimum pHe nor the pHe at the onset of the second rise in [K + ]e level differed significantly from their respective levels in the control group (Table II) .
In the verapamil group, VF occurred in 1 of the 9 control pigs at 22 minutes of ischemia, and no VF occurred in the 8 verapamil-treated pigs. In the pinacidil group, VF occurred in 3 of the 5 (60%) pigs in the control group at 27.5, 24.0, and 33.6 minutes of ischemia, respectively, but VF occurred in all 9 pigs in the pinacidil group (100%) at 18.1 ± 2.6 (5.5-32.2) minutes of ischemia (P = 0.110); however, the time to onset of VF was significantly shorter with pinacidil than with verapamil (P = 0.0332; Figure 2 , Table III ). The [K + ]e level during VF was significantly lower in the pinacidil group than in the control group (9.1 ± 0.41 versus 12.0 ± 0.88 mM, P = 0.0126, Table III ). The pHe during VF was higher in the pinacidil group than in the control group (6.99 ± 0.08 mM versus 6.29 ± 0.58, P = 0.0093, Table III ). Epicardial action potentials were recorded from the ischemic zone in each of the 3 pinacidil-treated pigs, and action potential 21) Whether these observations represent an important mechanism underlying the known antifibrillatory effect of verapamil 22, 23) cannot be determined because the calcium channel blockade exerts several additional effects that may be of equal or greater significance. These include suppression of action potentials dependent on the calcium inward current, 24) preservation of energy stores, 25) and mitochondrial protection. 26) In the present study, we did not record action potentials during ischemia. A previous report revealed that verapamil enhanced the ischemia-induced action potential shortening in vitro. ]e level was significantly less than that under the control condition. 16) In the in vivo pig model, the fall in pHe after administration of 10 μmol/L pinacidil was similar to that anticipated, whereas the fall in pHe after the administration of 25 μmol/L was less than that anticipated; however, with both 10 μmol/L and 25 μmol/L pinacidil in the pig and rabbit models of ischemia, APD was significantly shortened (in comparison to that under control conditions). 16) In these experiments, the ischemia time was limited to 6-8 minutes, and the incidence of arrhythmias was not assessed. 16) In the same protocol experiments, we evaluated the incidence of ST-T alternans during 8 minutes of ischemia in the in vivo pig model and found that ST-T alternans occurred in all 9 pigs at a mean onset time of 4.23 minutes ± 22 seconds during control ischemia; however, ST-T alternans did not occur during 8 minutes of ischemia after pinacidil administration. 28) Therefore, in the present study, we tested the effect of pinacidil on the incidence of VF during 60 minutes of ischemia. VF occurred in all 7 pigs treated with 25 μmol/L pinacidil. We then tested 10 μmol/L pinacidil in 2 pigs because we had previously reported that 10 μmol/L pinacidil affected the rise in [K + ]e level and pHe fall only minimally, but that it significantly shortened the APD during 6-8 minutes of ischemia; however, VF also occurred in these 2 pigs. Previous reports on the effect of ATPsensitive K + channel openers on the incidence of ventricular tachyarrhythmias were controversial; Chi et al. demonstrated the profibrillatory actions of pinacidil in a canine model of sudden coronary death; 29) Wolleben et al. revealed that the time to onset of serious ventricular rhythm disturbances was shortened; 30) Vegh et al. reported that levocromakalim did not significantly modify the arrhythmia severity during ischemia; 31) and D'Alonzo et al. revealed potential antiarrhythmic activity during ischema. 32, 33) The discrepant results may be due to 1) drug dosage, 2) route of drug administration, 3) drug specific effect, and 4) experimental design (in vivo versus in vitro, use of different animal species, and different ischemia duration). In the present study, VF occurred at a mean time of 18.1 ± 2.6 minutes of ischemia in the pinacidil group associated with marked shortening of APD. Therefore, it is possible that pinacidil may indicate proarrhythmic effects during acute myocardial ischemia through marked shortening of the APD despite the lesser rise in [K + ]e level and lesser pHe fall. Study limitations: The number of experiment in each group was small, and the action potential was recorded from only 3 experiments in the pinacidil group; moreover, the activation time from the ischemic myocardium was not evaluated. Furthermore, verapamil was administered intravenously and pinacidil was administered directly from the coronary artery, and the pinacidil dose was higher than the clinically effective concentration (1-2 μmol/L). Therefore, the effects of pinacidil on the rise in [K + ]e level and pHe fall and the incidence of ventricular arrhythmias during acute myocardial ischemia at the clinically relevant dose remain unclear.
Conclusion
VF may develop at a lesser rise in [K + ]e level and pHe fall in the presence of pinacidil during acute myocardial ischemia.
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